Insulet v. EOFlow: A $452 Million Verdict, an Avoided-Cost Theory, and the Limits of Trade-Secret Recovery
How a Massachusetts jury found a competing insulin-patch maker liable for misappropriating Omnipod design secrets — and why the court then cut the award by nearly 90 percent.